The U.S. Federal Trade Commission on Wednesday gave its blessing, with conditions, to the long-stalled $4.3 billion merger of a subsidiary of Denver-based dialysis provider DaVita Inc. with Optum, a health services company owned by insurance giant UnitedHealth Group.